Ing Groep Nv Kala Pharmaceuticals, Inc. Transaction History

Ing Groep Nv

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2018 May 07, 2018	SELL	$12.26 - $18.98 $398,450 - $616,850	-32,500 Closed	0 $0
Q4 2017 Feb 06, 2018	BUY	$13.68 - $23.17 $444,600 - $753,025	32,500	32,500 $601,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $7.83M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

Stay updated on Ing Groep Nv with notifications on news.